Synageva BioPharma Corp (GEVA): Hedge Funds and Insiders Are Bullish, What Should You Do?

Page 1 of 2

Is Synageva BioPharma Corp (NASDAQ:GEVA) undervalued? The smart money is turning bullish. The number of bullish hedge fund positions advanced by 1 recently.

In the 21st century investor’s toolkit, there are tons of indicators investors can use to track stocks. Some of the most useful are hedge fund and insider trading activity. At Insider Monkey, our studies have shown that, historically, those who follow the top picks of the best investment managers can outclass the market by a healthy amount (see just how much).

MILLENNIUM MANAGEMENTJust as key, positive insider trading sentiment is another way to break down the financial markets. As the old adage goes: there are many motivations for an executive to drop shares of his or her company, but only one, very clear reason why they would buy. Plenty of empirical studies have demonstrated the market-beating potential of this tactic if “monkeys” understand where to look (learn more here).

With these “truths” under our belt, we’re going to take a gander at the latest action regarding Synageva BioPharma Corp (NASDAQ:GEVA).

What does the smart money think about Synageva BioPharma Corp (NASDAQ:GEVA)?

In preparation for this quarter, a total of 7 of the hedge funds we track held long positions in this stock, a change of 17% from one quarter earlier. With the smart money’s capital changing hands, there exists a select group of key hedge fund managers who were increasing their holdings considerably.

Of the funds we track, Julian Baker and Felix Baker’s Baker Bros. Advisors had the largest position in Synageva BioPharma Corp (NASDAQ:GEVA), worth close to $506.5 million, accounting for 10.1% of its total 13F portfolio. On Baker Bros. Advisors’s heels is Richard Driehaus of Driehaus Capital, with a $10.6 million position; the fund has 0.4% of its 13F portfolio invested in the stock. Remaining hedgies with similar optimism include Israel Englander’s Millennium Management, Jim Simons’s Renaissance Technologies and Ken Griffin’s Citadel Investment Group.

As industrywide interest jumped, key money managers have been driving this bullishness. D E Shaw, managed by D. E. Shaw, assembled the largest position in Synageva BioPharma Corp (NASDAQ:GEVA). D E Shaw had 0.2 million invested in the company at the end of the quarter.

What have insiders been doing with Synageva BioPharma Corp (NASDAQ:GEVA)?

Insider trading activity, especially when it’s bullish, is most useful when the company in focus has seen transactions within the past half-year. Over the latest 180-day time frame, Synageva BioPharma Corp (NASDAQ:GEVA) has experienced 3 unique insiders purchasing, and 5 insider sales (see the details of insider trades here).

Let’s also take a look at hedge fund and insider activity in other stocks similar to Synageva BioPharma Corp (NASDAQ:GEVA). These stocks are Nektar Therapeutics (NASDAQ:NKTR), Acorda Therapeutics Inc (NASDAQ:ACOR), ImmunoGen, Inc. (NASDAQ:IMGN), Viropharma Inc (NASDAQ:VPHM), and Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY). This group of stocks are in the biotechnology industry and their market caps are closest to GEVA’s market cap.

Page 1 of 2
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The 10 Most Expensive Law Schools in the US

The 10 Best Wall Street Movies

The 10 Most Expensive Golf Clubs Ever Sold

The 10 Most Expensive Golf Memberships

The 10 Best Disney Characters Ever Created

The 8 Best Foods for Gaining Weight

The 10 Most Expensive Colleges in the World

The 7 Most Memorable Ad Campaigns of All Time

The 7 Most Expensive High Schools in the World

The 10 Electric Vehicles with the Longest Range

The 10 Cities with the Worst Drivers in the World

The 10 Most Expensive Dresses Ever Created

10 Islands to Visit Before You Die

10 Famous Celebrities Who Needed Rehab

The 15 Countries with the Largest Oil Reserves

The 10 Most Overused Excuses in the World

The 5 Best iOS Apps You Can’t Get on Android

5 Companies Damaged By Social Media Blunders

The 10 Most Legendary Blues Songs

The 10 Most Lawless Places in the World

4 Reasons China is a Threat to the US

The 17 Most Sugary Drinks in the World

The 10 Most Ruthless Rulers in History

The 10 Greatest Generals in History

Top 8 Travel Destinations for 2015

The 10 Safest Dog Breeds for Children

The 10 Most Stolen Vehicles in the US

The 7 Most Expensive Celebrity Weddings

The 10 Best LoL Teams in the World

Top 10 Worst Marketing Campaigns Ever Produced

Top 5 Diets that Help You Lose Weight

The 10 Best Ways to Stay Awake

7 Artists That Switched Musical Genres

The 10 Most Expensive Cities to Live in New Jersey

The 10 Best High Schools in New York

The 10 Countries With the Least Gender Inequality

The 6 Biggest Musician-Manager Feuds

The 10 Countries with the Cheapest Gas Prices

The 7 Most Theatrical Bands of All Time

The 8 Worst Band Breakups of All Time

The 10 Most Important South American Leaders

The 7 Most Successful Casting Show Winners

The 10 Most Peaceful Countries in the World

5 Big Reasons Communism Failed

The 15 Most Famous Carl Icahn Quotes

10 Scary Animals that are Actually Harmless

The 8 Most Famous Singer-Actors in Entertainment

The 10 Longest Wars of All Time

The 13 Worst Looking Foods that Taste Great

The 6 Most Gruesome Injuries Suffered During a Sports Match

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!